Cost‐effectiveness and cost‐utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (prozac) in treating depression: a randomized clinical trial
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Cost‐effectiveness and cost‐utility of cognitive therapy (CT), rational emotive behavioral therapy (REBT), and fluoxetine (Prozac) for major depressive disorder (MDD) were compared in a randomized clinical trial with a Romanian sample of 170 clients. Each intervention was offered for 14 weeks, plus three booster sessions. Beck Depression Inventory (BDI) scores were obtained prior to intervention, 7 and 14 weeks following the start of intervention, and 6 months following completion of intervention. CT, REBT, and fluoxetine did not differ significantly in changes in the BDI, depression‐free days (DFDs), or Quality‐Adjusted Life Years (QALYs). Average BDI scores decreased from 31.1 before treatment to 9.7 six months following completion of treatment. Due to lower costs, both psychotherapies were more cost‐effective, and had better cost‐utility, than pharmacotherapy: median $26.44/DFD gained/month for CT and $23.77/DFD gained/month for REBT versus $34.93/DFD gained/month for pharmacotherapy, median $/QALYs=$1,638, $1,734, and $2,287 for CT, REBT, and fluoxetine (Prozac), respectively. © 2008 Wiley Periodicals, Inc. J Clin Psychol 65:1–17, 2009.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The empirical status of cognitive-behavioral therapy: A review of meta-analyses
Butler, A. C., Chapman, J. E., Forman, E. M., & Beck, A. T. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.07.003 · Cited by 3,215
Defining empirically supported therapies.
Chambless, D. L., & Hollon, S. D. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.1.7 · Cited by 3,067 · cited 1×
“As advocated by Chambless and Hollon (1988), ‘‘y in evaluating the benefits of a given treatment, the greatest weight should be given to efficacy trials but that these trials should be followed by research on effectiveness in clinical settings and with various populations and by cost-effectiveness…”
BackgroundMoher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Evidence-based practice in psychology.
American Psychological Association (2006) · American Psychologist · doi:10.1037/0003-066x.61.4.271 · Cited by 2,478
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300 · cited 2×
“As with many other clinical trials for depression treatments (e.g., the National Institute of Mental Health Treatment of Depression Collaborative Research Program; Elkin et al., 1989), and following the American Psychiatric Association (2000) guidelines for treatment of MDD, we excluded a placebo treatment condition.”
MethodA component analysis of cognitive-behavioral treatment for depression.
Jacobson, N. S., Dobson, K. S., Truax, P. A., Addis, M. E., Koerner, K., Gollan, J. K., Gortner, E., & Prince, S. E. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.2.295 · Cited by 1,413
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989 · cited 2×
“These dropout rates may be lower than usual due to the use of a different population in a different healthcare system than is usually the case in published studies, but other researchers have reported reasonably comparable attrition rates of 15% for CBT and 16% for medication (DeRubeis et al., 2005).”
ResultA meta-analysis of the efficacy of cognitive therapy for depression.
Dobson, K. S. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.57.3.414 · Cited by 823 · cited 1×
“We chose Beck’s CT, a common form of CBT, because it is a widely used psychotherapy for depression with a considerable evidence base (e.g., American Psychiatric Association, 2000; DeRubeis, Gelfand, Tang, & Simons, 1999; Dobson, 1989; Hollon, Shelton, & Davis, 1993).”
MethodAraya, R., Flynn, T., Rojas, G., Fritsch, R., & Simon, G. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1379 · Cited by 128
Cost-Effectiveness of Cognitive–Behavioural Therapy and Drug Interventions for Major Depression
Vos, T., Corry, J., Haby, M. M., Carter, R., & Andrews, G. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01652.x · Cited by 114
A sadly neglected cognitive element in depression
Ellis, A. (1987) · Cognitive Therapy and Research · doi:10.1007/bf01183137 · Cited by 95
Cited by
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
Kennedy, J. L., Altar, C. A., Taylor, D. L., Degtiar, I., & Hornberger, J. C. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836508e6 · Cited by 392
“In comparison with other mental disorders, TRS has a less severe utility weight (i.e. quality of life, 0.61) than major depressive disorder patients who do not respond to therapy (0.3–0.55) (Nuijten, 2001; Sava et al., 2009; Benedict et al., 2010).”
BackgroundInfluentialJohnston, K. M., Powell, L. C., Anderson, I. M., Szabo, S., & Cline, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.045 · Cited by 321
A review of empirically supported psychological therapies for mood disorders in adults
Hollon, S. D., & Ponniah, K. (2010) · Depression and Anxiety · doi:10.1002/da.20741 · Cited by 267
Amick, H. R., Gartlehner, G., Gaynes, B. N., Forneris, C., Asher, G. N., Morgan, L. C., Coker-Schwimmer, E., Boland, E., Lux, L. J., Gaylord, S., et al. (2015) · BMJ · doi:10.1136/bmj.h6019 · Cited by 181
Metadata
- Authors
- Sava, F. A., Yates, B. T., Lupu, V., Szentagotai, A., & David, D.
- Venue
- Journal of Clinical Psychology
- Publisher
- Wiley
- Published
- 2008-12-02
- Volume
- 65
- Issue
- 1
- Pages
- 36-52
- ISSN
- 0021-9762 (ISSN-L)
- 1097-4679
- OpenAlex
- W2097704950
- Cited by
- 82
- References
- 12
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.